2009
DOI: 10.1158/1078-0432.ccr-09-1678
|View full text |Cite
|
Sign up to set email alerts
|

Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2

Abstract: Purpose: Colon cancer is a major cause of cancer deaths. Dietary factors contribute substantially to the risk of this malignancy. Western-style diets promote development of azoxymethane-induced colon cancer. Although we showed that epidermal growth factor receptors (EGFR) controlled azoxymethane tumorigenesis in standard fat conditions, the role of EGFR in tumor promotion by high dietary fat has not been examined. Experimental Design: A/J × C57BL6/J mice with wild-type Egfr (Egfr wt ) or loss-offunction waved-… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
60
2

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(66 citation statements)
references
References 37 publications
4
60
2
Order By: Relevance
“…Moreover, colitis was worsened by EGFR inactivation, with a 44% mortality rate among Egfr wa5 mice during DSS administration, whereas no wild-type mice died during this period. These data differ from those of Dougherty et al, who showed that EGFR inactivation (Egfr wa2/wa2 ) reduced tumorigenesis following AOM/DSS, albeit only in the setting of diet-induced obesity (34). However, their conclusions are complicated by their use of mice on a mixed A/J × C57BL/6 background, since A/J mice are exquisitely susceptible to AOM-induced colon tumorigenesis, even without an inflammatory stimulus (58).…”
Section: Figurecontrasting
confidence: 59%
See 1 more Smart Citation
“…Moreover, colitis was worsened by EGFR inactivation, with a 44% mortality rate among Egfr wa5 mice during DSS administration, whereas no wild-type mice died during this period. These data differ from those of Dougherty et al, who showed that EGFR inactivation (Egfr wa2/wa2 ) reduced tumorigenesis following AOM/DSS, albeit only in the setting of diet-induced obesity (34). However, their conclusions are complicated by their use of mice on a mixed A/J × C57BL/6 background, since A/J mice are exquisitely susceptible to AOM-induced colon tumorigenesis, even without an inflammatory stimulus (58).…”
Section: Figurecontrasting
confidence: 59%
“…However, a major criticism of this approach is that EGFR activation might accelerate tumorigenesis (29). Indeed, EGFR is widely considered a tumor promoter; its expression or activation is increased in many colonic precancerous lesions and tumors (30)(31)(32), and EGFR is implicated in animal models of gastrointestinal tumorigenesis (25,(33)(34)(35)(36). Moreover, EGFR monoclonal antibodies are approved for metastatic colorectal cancer treatment (cetuximab and panitumumab) (37).…”
Section: Introductionmentioning
confidence: 99%
“…A placebo-controlled RCT in individuals with FAP found decreased incidence of adenoma with administration of 2 g/day of omega-3 PUFAs for 6 months [96]. In preclinical animal studies, dietary fat has been linked to higher incidence of colon cancer, [97] and a number of animal studies have demonstrated efficacy of several fish oil preparations against CRC [98][99][100][101].…”
Section: Fat and Omega-3 Fatty Acidsmentioning
confidence: 99%
“…In a study of A/J x C57BL6/J mice (obesity prone) versus wild type mice, showed the involvement of epidermal growth factor receptors (EGFR) in controlled azoxymethane tumorigenesis using a normal (5%) fat diet, versus high fat western diet (20%). On a high fat diet, mice displayed more weight gain and also insulin resistance with significantly increased tumor and cancer incidence, suggesting EGFR as a pivotal gene up-regulated for obesity and tumour growth (Dougherty et al, 2009).…”
Section: Discussionmentioning
confidence: 99%